Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
This article breaks down the components that feed a Total Return Index, including price changes, dividends, and corporate actions, and explains how they combine to show true performance.
28,383 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Bank of America signals a noticeable pullback in card use across its customers, adding to a growing picture of cautio...
Broadcom’s AI-driven revenue surge is reshaping the chip landscape, prompting persistent buying from a longtime inves...
Kanen Wealth Management added a substantial stake in Compass, prompting questions about compass stock after kanen. Th...
A large insider stake in Veris Residential stock signals conviction from an established manager. This article explain...
Snap Inc has faced a severe share-price drop, but a mix of AR hardware progress, AI-enhanced ads, and international g...
OpenAI secures a historic $110 billion funding round from Amazon, Nvidia and SoftBank, driving its valuation to about...
A small, overlooked quantum company could ride a wave of lab-to-market commercialization. This guide breaks down why ...
Digital asset funds snapped a five-week bleed with a $1 billion inflow, led by Bitcoin and Ethereum, signaling a caut...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
Institutional appetite for bitcoin ETFs intensified, with roughly $1.15 billion flowing in over the latest week and a...
A detailed look at Seer’s Q1 2026 earnings, the forces shaping growth, and practical moves investors can make now. Le...